Home Nav
Nextech Invest Logo

Carmen Diez

Alfred Scheidegger

Prior to joining Nextech in 2018, Dr. Diez worked as a Postdoctoral Researcher at University Children’s Hospital Zurich, where she specialized on the development of novel therapies for metabolic rare disorders and cancer. In parallel, she worked part time as private equity analyst at HBM Partners (Switzerland). She received the M.Sc. degree in Medical Biotechnology and Ph.D in Biotechnology from Universidad Politécnica de Valencia, Spain. Throughout her studies, she gained international experience in specific areas of biomedicine at KTH Biotechnology (with Prof. Mathias Uhlén), Bergen University and University Children’s Hospital Zurich (Switzerland).


Personalized Oncology 2019 conference

23.06. – 25.06.2019

Basel, Switzerland

  • 24.07.2019

    Kura Oncology’s Menin-MLL Inhibitor KO-539 Receives...

  • 18.07.2019

    Blueprint Medicines Announces European Medicines Agency...

  • 15.07.2019

    Neon Therapeutics ’ Personal Neoantigen Vaccine Study...


Newsletter Registration

Please fill in the subscription form completely. If you wish to modify your personal data or to change/cancel your newsletter subscription, this is possible at any time.

A link to your subscription profile can be found in every newsletter email.


* Compulsory fields


Newsletter Registration

Your eMail have been successfully registered.